Social Prescribing for a Mindful Lifestyle
The goal of this clinical trial is to evaluate the effectiveness of an 8-week mindfulness lifestyle social prescribing program in community-dwelling older adults aged 55 and older. The main questions it aims to answer are:
To establish a mindfulness lifestyle social prescribing model applied to the psychological and social health promotion of middle-aged and older populations.
To evaluate the effectiveness of the intervention on improving depressive symptoms, loneliness, and quality of life in this population.
Participants will receive an 8-week group intervention program, with each weekly session lasting approximately 3 hours. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). Researchers will collect and evaluate data from pre- and post-intervention assessments to measure changes in depressive symptoms, loneliness risk, and overall quality of life.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
This clinical trial implements an 8-week mindfulness lifestyle social prescribing program designed to enhance the psychological and social well-being of community-dwelling older adults. The intervention integrates mindfulness practices with healthy lifestyle modifications to address sub-healthy states, such as depressive symptoms and social isolation, which traditional clinical models often fail to fully resolve.
The structured 8-week group curriculum meets weekly for 3 hours per session. The program systematically incorporates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (including herbal therapy and leaf printing).
The program is delivered by a multidisciplinary team of geriatricians, geriatric case managers, nutritionists, exercise instructors, and trained volunteers to ensure comprehensive support.
Research procedures involve a pre- and post-intervention assessment design. Participants will undergo standardized evaluations before the commencement of the first session (Week 1) and upon the completion of the program (Week 8). These assessments will objectively measure changes in depressive symptoms, the risk of loneliness, and overall quality of life to determine the effect of this social prescribing model.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Sheng-Lun Kao, MD. PhD.
- Número de telefone: 15599 +886-3-8561825
- E-mail: stevenkao7434@gmail.com
Locais de estudo
-
-
Taiwan
-
Hualien City, Taiwan, Taiwan, 97071
- Buddhist Tzu Chi General Hospital
-
Contato:
- Sheng-Lun Kao, MD. PhD.
- Número de telefone: 15599 +886-3-8561825
- E-mail: stevenkao7434@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- People aged 55 years or older.
- People with a Geriatric Depression Scale (GDS-15) score of 7-10 or a UCLA Loneliness Scale Version 3 score of 35-64.
- People can understand the research process, meet the requirements of the research, and can sign the informed consent and participate in the project.
Exclusion Criteria:
- People that are unable to cooperate with the project or follow-up.
- According to the PI's judgment, people with severe or poorly controlled conditions include ongoing acute diseases, severe infections, severe abnormal laboratory tests, or serious medical conditions with the following systems: cardiovascular, pulmonary, hepatic, nervous, mental, metabolic, renal, musculoskeletal, gastrointestinal, etc.
- People with severe depression, risk of self-harm, severe cognitive impairment (dementia), visual or hearing impairment, and disabilities that prevent the completion of the project and assessment.
- People are currently or expected to join any other physical training courses or nutrition intervention plans during the project period.
- Others are based on the judgment of the PI that participating in this project may adversely affect the safety of the subjects, hinder the progress of the experiment, or interfere with the evaluation of the outcomes of the project.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Braço Experimental
|
An 8-week, once-weekly, 3-hour group program designed for middle-aged and older adults.
The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing).
It is delivered by a multidisciplinary team including geriatricians, case managers, dietitians, exercise instructors, and volunteers.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in Geriatric Depression Scale (GDS-15) score
Prazo: Baseline and Week 8
|
The Geriatric Depression Scale (GDS-15) is a 15-item questionnaire used to assess depression symptoms in older adults.
Scores range from 0 to 15, with higher scores indicating more severe depressive symptoms.
|
Baseline and Week 8
|
|
Changes in UCLA Loneliness Scale score
Prazo: Baseline and Week 8
|
The UCLA Loneliness Scale measures an individual's subjective feelings of loneliness and social isolation.
Scores range from 20 to 80, with higher scores indicating greater loneliness.
|
Baseline and Week 8
|
|
Changes in WHOQOL-BREF questionnaire score
Prazo: Baseline and Week 8
|
The World Health Organization Quality of Life-BREF (WHOQOL-BREF) Taiwan version is a 28-item questionnaire used to assess the physical, psychological, social relationships, and environment domains of quality of life.
Scores for each domain are transformed to a scale of 4 to 20, with higher scores indicating better quality of life.
Changes in scores were evaluated between baseline and week 8.
|
Baseline and Week 8
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Sheng-Lun Kao, MD. PhD., Buddhist Tzu Chi General Hospital
Publicações e links úteis
Publicações Gerais
- Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015 Mar;10(2):227-37. doi: 10.1177/1745691614568352.
- Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010 Jul 27;7(7):e1000316. doi: 10.1371/journal.pmed.1000316.
- Paquet C, Whitehead J, Shah R, Adams AM, Dooley D, Spreng RN, Aunio AL, Dube L. Social Prescription Interventions Addressing Social Isolation and Loneliness in Older Adults: Meta-Review Integrating On-the-Ground Resources. J Med Internet Res. 2023 May 17;25:e40213. doi: 10.2196/40213.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- IRB115-107-A
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .